Clinical Trial Update: Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study [Phase 4]

View source ↗

Summary

A multicenter Phase 4 prospective study evaluating hematopoietic stem cell transplantation in patients with thalassemia major has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Thalassemia Major | Phase 4 | Status: COMPLETED